Oncolytics Biotech (Canada)
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Oncolytics Biotech (Canada), Canada, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
48%
Total
Publications
245
Total Open
Publications
118
Total
Citations
7.2K
Open Access
Percentage
48%
Total
Publications
245
Total Open
Publications
118
Total
Citations
7.2K
Breakdown
Publisher Open
17%
Both
23%
Other Platform Open
8%
Closed
52%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 45%
43
Hybrid 27%
26
No Guarantees 28%
27
Other Platform Open
Domain 72%
54
Other Internet 27%
20
Institution 7%
5
Preprint 4%
3
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 54 |
DOI | Other Internet | 20 |
Europe PMC | Domain | 3 |
University of Melbourne | Institution | 1 |
University of Arizona | Institution | 1 |
universiteitleiden.nl OAI-PMH Repository | Institution | 1 |
Royal Netherlands Academy of Arts and Sciences | Institution | 1 |
Research Square | Preprint | 1 |
medRxiv | Preprint | 1 |
Jackson Laboratory | Institution | 1 |